Skip to main content
Home

oAv Menu

  • Home
  • Patient Care Center
  • Clinical Trials
  • Providers
    • Therapeutics
    • People
    • Places
  • Community Center
    • Community Stories
    • Social Media
    • Community Content
    • Financial Assistance
  • News
    • Community Events
    • Clinical Trials and Research
    • Business
    • News People
    • Happenings
    • Spotlight
    • Fundraising Events
  • Trusted Resources
    • Education
    • Videos & Visuals
  • Event Calendar
  • Login
  • Search
Attruby opened box
BridgeBio secures $300 million from royalty financing, enhancing its financial position for Attruby® launch and pipeline development.

News

Nature aging
Serum amyloid P secreted by bone marrow adipocytes drives skeletal amyloidosis
Jul 29, 2025
Reuters
AstraZeneca therapy for clearing protein deposits fails main goal in late-stage study
Jul 16, 2025
Fiercebiotech
AstraZeneca’s AL amyloidosis drug fails to reduce mortality in phase 3 test
Jul 16, 2025
ScienceDirect
Challenges in Diagnosing Systemic Amyloidosis
Jul 16, 2025
Nature
Incidence and prevalence of light chain amyloidosis in the United States in 2019–2021 using Optum EHR data
Jul 11, 2025
More in News

Education

National Library of Medicine
Educational attainment, electroencephalographic rhythms, cortical structure, and cognitive performance over 2 years in older adults with subjective memory complaints and brain amyloidosis
Jul 14, 2025
National Library of Medicine
Tolerability and efficacy of sodium-glucose co-transporter 2 inhibitors in patients with cardiac amyloidosis: a meta-analysis of observational studies
Jul 07, 2025
National Library of Medicine
Cytological Diagnosis of Amyloidosis From Orbital Papules
Jul 01, 2025
cureus
Amyloid Light-Chain (AL) Amyloidosis in a Middle-Aged Lady: Confronting the Challenges of a Rare Diagnosis in a Developing Country
Jun 07, 2025
European Heart Journal Supplements
Cardiac transthyretin amyloidosis treatment improves outcomes after aortic valve replacement for severe stenosis
Jun 02, 2025
More in Education

Community Center

Confirming the Benefit of SGLT2 Inhibitors in People With ATTR Amyloidosis, with Justin Riley Lam, MD
Apr 05, 2025
Health Value Surgery
Dottie’s Travel Alert for TAVR Patients
Apr 02, 2025
ScienceDirect
Advance Insulin Injection Technique and Education With FITTER Forward Expert Recommendations
Apr 01, 2025
BioSpace
Alnylam Presents New Data from the HELIOS-B Phase 3 Study of Vutrisiran in Patients with ATTR Amyloidosis with Cardiomyopathy (ATTR-CM) at the American College of Cardiology’s Annual Scientific Session 2025
Mar 31, 2025
Connecting with amyloidosis
Connecting with amyloidosis patients and caregivers in N.Z.
Mar 12, 2025
More in Community Center

Hot Topics

Healthy Meal Planning
Healthy Meal Planning: Tips for Older Adults
Mar 12, 2025
An Elderly Mother and an Aging Son
An Elderly Mother and an Aging Son: A Journalist’s Caregiving Story
Mar 07, 2025
Patient Safety and Quality: An Evidence-Based Handbook for Nurses
Supporting Family Caregivers in Providing Care
Mar 04, 2025
Caregiver Responsibilities
Live-In Caregivers for Elderly
Feb 26, 2025
Hidden Cost of Caregiving
The Hidden Cost of Caregiving: Stress, Anxiety, and Coping Mechanisms
Jan 23, 2025

Video

Newsletter

Stay informed - subscribe to our newsletter.
The subscriber's email address.

Featured Trials

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ALN-TTRSC04 in Healthy Subjects
Collection of Samples and Clinical Data From Patients With Amyloid Diseases
Ohio State University Multiple Myeloma and Amyloidosis Data Registry and Sample Resource
Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders
Post Approval Study of Lixelle for the Treament of Dialysis-Related Amyloidosis

Footer menu

  • Home
  • About us
  • Video
  • Galleries
  • Contact
  • Login
  • Privacy Policy
  • Privacy Reminder
  • Terms of use
  • FAQ
  • Code of Conduct

© 2025 Somebody To Talk To, Inc.

Join us on                     
Alnylam Logo external link, opens in a new tabPfizer Logo external link, opens in a new tabBridgebio Logo external link, opens in a new tabAttralus Logo external link, opens in a new tabProthena Logo external link, opens in a new tab
Amyloidosis Foundation Logo external link, opens in a new tab